UK markets close in 8 hours 21 minutes

ICU Medical, Inc. (ICUI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
98.29+0.37 (+0.38%)
At close: 04:00PM EDT
98.29 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.40B
Enterprise value 3.85B
Trailing P/E N/A
Forward P/E 20.70
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.05
Price/book (mrq)1.13
Enterprise value/revenue 1.70
Enterprise value/EBITDA 15.19

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3-46.91%
S&P500 52-week change 323.57%
52-week high 3212.43
52-week low 378.28
50-day moving average 3101.07
200-day moving average 3110.68

Share statistics

Avg vol (3-month) 3248.04k
Avg vol (10-day) 3157.6k
Shares outstanding 524.37M
Implied shares outstanding 624.37M
Float 821.01M
% held by insiders 112.86%
% held by institutions 189.90%
Shares short (15 Apr 2024) 41.2M
Short ratio (15 Apr 2024) 44.88
Short % of float (15 Apr 2024) 47.86%
Short % of shares outstanding (15 Apr 2024) 44.93%
Shares short (prior month 15 Mar 2024) 4959.5k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:2
Last split date 318 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -1.31%
Operating margin (ttm)-0.93%

Management effectiveness

Return on assets (ttm)0.67%
Return on equity (ttm)-1.41%

Income statement

Revenue (ttm)2.26B
Revenue per share (ttm)93.78
Quarterly revenue growth (yoy)1.70%
Gross profit (ttm)N/A
EBITDA 276.61M
Net income avi to common (ttm)-29.66M
Diluted EPS (ttm)-1.23
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)278.98M
Total cash per share (mrq)11.56
Total debt (mrq)1.7B
Total debt/equity (mrq)80.28%
Current ratio (mrq)2.54
Book value per share (mrq)87.96

Cash flow statement

Operating cash flow (ttm)166.2M
Levered free cash flow (ttm)162.25M